Form D · Biotechnology
Pinnacle Transplant Technologies, LLC
Phoenix, AZ · CIK 0001638523
Offering snapshot reported Apr 9, 2015 · SEC filing
- Reported sold
- $2.45M Offering amount: $2.45M
- Investors reported
- 14 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Feb 10, 2011 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Apr 9, 2015 | Initial | $2,450,000 | No comparison | 14 | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-237654
Source: Form D, filed Apr 9, 2015. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Gabriel Hyams | Promoter |
| Merrill Stromer | Promoter |
| Russell D Yelton | Executive |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
1125 W. Pinnacle Peak Rd., Bldg. #2
Phoenix, AZ, 85027
Phoenix, AZ, 85027